Covid19
Fourth COVID-19 Vaccine, From Novovax, Passes Key FDA Stage – TIME

The FDA's advisory committee on vaccines unanimously recommended Novovax's COVID-19 shot. If authorized it will be the fourth in the U.S..
The FDA's advisory committee on vaccines unanimously recommended Novovax's COVID-19 shot. If authorized it will be the fourth in the U.S..